Figure 3.
The effect of gefitinib on tumour-derived cells from recurrent ovarian cancer (n = 13). Legend Some tumours show increased sensitivity (lower IndexSUM), while others show enhanced resistance (higher IndexSUM)
The effect of gefitinib on tumour-derived cells from recurrent ovarian cancer (n = 13). Legend Some tumours show increased sensitivity (lower IndexSUM), while others show enhanced resistance (higher IndexSUM)